Latest filing published 15 Jun 2021 for PMV Pharmaceuticals, Inc., €65k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Euclidean Capital LLC: trading record in brief
Euclidean Capital LLC is a declared insider of PMV Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 29 September 2020 and 14 June 2021, the trades on record add up to 34 filings.
On the market, this insider has only sold: 30 sales, €5.2M in total. Since January 2021: no purchases and 30 sales on the market.
On 15 June 2021 came the latest disclosure, an open-market sale for €91k in PMV Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Euclidean Capital LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,324 shares@ US$33.8023.8% of flowCommon StockSEC:0001062993-21-005709:0
- 4,192 shares@ US$33.6442.7% of flowCommon StockSEC:0001062993-21-005572:0
- 3,291 shares@ US$33.6233.5% of flowCommon StockSEC:0001062993-21-005496:0
3 of 3 declarations
